March 02, 2015 6:48 PM ET


Company Overview of Shire Canada Inc.

Company Overview

Shire Canada Inc. provides therapies for attention deficit hyperactivity disorders (ADHDs) in children and adolescents in Canada. The company focuses on ADHD and human genetic therapies, as well as gastrointestinal and renal diseases. It also provides antiretroviral treatment options for persons with HIV or Hepatitis B. Shire Canada Inc. was formerly known as Shire BioChem Inc. and changed its name to Shire Canada Inc. in September 2007. Shire Canada Inc. was incorporated in 1972 and is based in Saint-Laurent, Canada. As of May 11, 2001, Shire Canada Inc. operates as a subsidiary of Shire plc.

2250 Alfred-Nobel Boulevard

Suite 500

Saint-Laurent, QC H4S 2C9


Founded in 1972





Key Executives for Shire Canada Inc.

Chief Executive Officer and President
Age: 68
Chief Financial Officer
Chief Operating Officer and Director
Age: 67
Executive Vice President of Investments and Executive Vice President of Subsidiaries
Age: 57
Vice President - Legal Affairs and Corporate Secretary
Compensation as of Fiscal Year 2014.

Shire Canada Inc. Key Developments

Shire Canada Inc. Announces DERMAGRAFT Now Available in Canada for the Treatment of Diabetic Foot Ulcers

Shire Canada Inc. announced that DERMAGRAFT (human fibroblast-derived dermal substitute) is now available in Canada for the treatment of diabetic foot ulcers (DFUs) greater than 6 weeks duration, which extend through the dermis, but without tendon, muscle, joint capsule, or bone exposure. Health Canada issued a license for DERMAGRAFT as a class IV medical device designed to be externally applied onto DFUs. DERMAGRAFT is manufactured from human fibroblast cells derived from donated newborn foreskin tissue. During the manufacturing process, the human fibroblasts are seeded onto a bioabsorbable scaffold. The fibroblasts proliferate to fill the interstices of this scaffold and secrete human dermal collagen, matrix proteins, growth factors, and cytokines to create a three-dimensional human dermal substitute containing metabolically active, living cells.

Similar Private Companies By Industry

Company Name Region
Viridis Biotech Americas
Bioniche Animal Health Canada Inc. Americas
BioNiche, Inc. Americas
Prempharm Inc. Americas
Valeo Pharma Inc. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Shire Canada Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at